Where is the Growth Potential in Large Cap Biopharmaceutical Companies? Caution: Risk Aversion Remains High Investing in biotech stocks ain’t getting easier. The sector is underperforming the marke...
Like Bill Murray it feels like a bad Groundhog’s Day again as markets moved right back down in volatile, what I believe, is a descending spiral. For bulls, just when you think markets are ready for ...
One way to lose a war is to focus on preparing to fight the last war. Preparing to fight the last war is a characteristic of losing generals, militaries and nations. The same is true of finance and e...
Every year can be defined by a few key events that shape the entire outcome and affect everybody’s lives. With that in mind, here are our three boldest predictions for what will end up being some of...
By ignoring unintended consequences – spinning around global monetary or interest rate policy moves (especially the trend toward negative rates we took to task quite extensively last night); th...
The Chart of the Day belongs to NextEra Energy (NYSE: NEE). I found the electric services stock by sorting Barchart’s All Time High list for the highest technical buy signals, then used t...
Stocks began the session in negative territory and remained there throughout the entire session. The early weakness was attributed to oil prices, which were down early and never recovered during the d...
USDJPY: Having the pair sold off hard on Tuesday, further downside pressure is likely in the days ahead. On the downside, support comes in at the 119.50 level where a break if seen will aim at the 119...
Savills, a global real estate services provider listed on the London Stock Exchange, has released its annual report on the role that real property plays in the investment world. Here are some of its k...